Pain, Postoperative
Conditions
Brief summary
Living donor liver transplantation has become a common treatment option for patients with end-stage liver disease. Donor hepatectomy is associated with significant postoperative pain due to inverted L-shaped incision. Therefore adequate analgesia is important for recovery. Erector Spinae Plane Block (ESPB) is a safe anesthesia technique used to provide postoperative analgesia. This study aimed to compare the novel ultrasound-guided ESPB technique with controls in terms of postoperative opioid consumption and postoperative pain control on donor patients.
Interventions
PROCEDUREErector Spinae Plane Block
Intravenous fentanyl patient control device 48-hour fentanyl consumption will be recorded.
Intravenous fentanyl patient control device 48-hour fentanyl consumption will be recorded.
Sponsors
Medipol University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Masking description
The patient and the anesthesiologist who performs postoperative pain evaluation will not know the group.
Intervention model description
There are two model for this study. The first group is erector spinae plane block group. The second one is control group.
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Donor patients scheduled for elective hepatectomy in liver transplantation surgery * ASA I-II * Patients who are aged between 18-65
Exclusion criteria
* Patients who do not accept the procedure * Skin infection at the site of Erector Spina Plan Block area * Coagulation disorder or using anticoagulant drugs * Known local anesthetics and opioid allergy * Severe pulmonary and/or cardiovascular problems * Substance addiction or known psychiatric or mental problems * Chronic painkiller usage * Pregnancy or lactation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Opioid consumption | Change from baseline opioid consumption at postoperative 0, 2, 4, 6, 12, 24, 36 and 48 hours | The amount of fentanyl required by the patient and given by the device will be recorded for the first 48 hours. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analog Scale | Change from baseline pain scores at postoperative 0, 2, 4, 6, 12, 24, 36 and 48 hours | Pain of patients will be evaluated and recorded according to the Visual Analog Scale. |
Countries
Turkey (Türkiye)
Outcome results
None listed